Article
Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours.
British journal of cancer - 4 Nov 2002
Ozdağ H, Batley S J, Försti A, Iyer N G, Daigo Y, Boutell J, Arends M J, Ponder B A J, Kouzarides T, Caldas C
Abstract excerpt
In this study we screened the histone acetyltransferases CBP and PCAF for mutations in human epithelial cancer cell lines and primary tumours. We identified two CBP truncations (both in cell lines), seven PCAF missense variants and four CBP intronic microdeletions. These data suggest that neither gene is commonly inactivated in human epithelial cancers.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.